Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-18-024357
Filing Date
2018-10-17
Accepted
2018-10-17 06:03:54
Documents
6
Period of Report
2018-10-17

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20181012.htm 6-K 25477
2 EX-99.1 meso-ex991_6.htm EX-99.1 32020
3 EX-99.2 meso-ex992_7.htm EX-99.2 196799
4 GRAPHIC g4kzi2xl4d52000001.jpg GRAPHIC 5399
5 GRAPHIC g4kzi2xl4d52000002.jpg GRAPHIC 10298
6 GRAPHIC g3d02p14zwb5000001.jpg GRAPHIC 1430
  Complete submission text file 0001564590-18-024357.txt   279399
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 181125358
SIC: 2836 Biological Products, (No Diagnostic Substances)